erythromycin has been researched along with diazepam in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (25.71) | 18.7374 |
| 1990's | 2 (5.71) | 18.2507 |
| 2000's | 13 (37.14) | 29.6817 |
| 2010's | 11 (31.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Abbas, SY; Aly, MM; Basyouni, WM; El-Bayouki, KA; Mohamed, YA | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Beaumont, K; Di, L; Maurer, TS; Smith, DA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Warkany, J | 1 |
| Friedman, GD; Selby, JV | 1 |
| Rajka, G | 1 |
| Hiller, FC; Olsen, KM | 1 |
| Nguyen, P; Pibouin, M; Renouard, A; Tillement, JP; Zini, R | 1 |
| Mihailova, K; Windorfer, A | 1 |
| Mihailova, K; Pringsheim, W; Windorfer, A | 1 |
| Aoki, Y; Sugano, T; Sugiura, Y; Uchida, M | 1 |
| Trzaski, M | 1 |
| Luurila, H; Neuvonen, PJ; Olkkola, KT | 1 |
| Fowler, SM; Friedberg, T; Pritchard, MP; Riley, RJ; Sutcliffe, MJ; Wolf, CR | 1 |
| Fowler, SM; Friedberg, T; Riley, RJ; Taylor, JM; Wolf, CR | 1 |
| ARIAS, S; NEGRETE, D; RUIZSANCHEZ, A; RUIZSANCHEZ, F | 1 |
| Dey, S; Gunda, S; Mitra, AK | 1 |
| Chaudhary, A; Drijfhout, WJ; Garner, RC; Jochemsen, R; Kneer, J; Kuhnz, W; Lappin, G; Oosterhuis, B; Rowland, M | 1 |
1 review(s) available for erythromycin and diazepam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for erythromycin and diazepam
| Article | Year |
|---|---|
Interaction between erythromycin and the benzodiazepines diazepam and flunitrazepam.
Topics: Adult; Animals; Antioxidants; Aspartate Aminotransferases; Bepridil; Biphenyl Compounds; Cross-Over Studies; Diazepam; Double-Blind Method; Drug Interactions; Erythromycin; Female; Flunitrazepam; Free Radicals; Humans; L-Lactate Dehydrogenase; Lipid Peroxidation; Lipoxygenase Inhibitors; Liver; Male; Picrates; Rats; Rats, Wistar | 1996 |
Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Area Under Curve; Carbon Radioisotopes; Chromatography, Liquid; Cross-Over Studies; Diazepam; Dose-Response Relationship, Drug; Drug Monitoring; Erythromycin; Estradiol; Female; GABA Modulators; Humans; Injections, Intravenous; Male; Mass Spectrometry; Midazolam; Middle Aged; Warfarin | 2006 |
32 other study(ies) available for erythromycin and diazepam
| Article | Year |
|---|---|
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Synthesis of some new 4(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones and their metal complexes and a study on their anticonvulsant, analgesic, cytotoxic and antimicrobial activities - part-1.
Topics: Analgesics; Animals; Anti-Infective Agents; Anticonvulsants; Antineoplastic Agents; Bacteria; Cell Line, Tumor; Female; Fungi; Lethal Dose 50; Mice; Microbial Sensitivity Tests; Organometallic Compounds; Pentylenetetrazole; Rats; Seizures; Thiosemicarbazones | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Volume of Distribution in Drug Design.
Topics: Drug Design; Half-Life; Pharmacokinetics | 2015 |
A warfarin embryopathy?
Topics: Abnormalities, Drug-Induced; Alcoholism; Chondrodysplasia Punctata; Diazepam; Digitalis Glycosides; Erythromycin; Female; Fetus; Heart Valve Prosthesis; Heparin; Humans; Infant, Newborn; Penicillin G Benzathine; Pregnancy; Pregnancy Complications; Sulfisoxazole; Syphilis; Thrombosis; Warfarin | 1975 |
Epidemiological screening for potentially carcinogenic drugs.
Topics: Barbiturates; Breast Neoplasms; Carcinogens; Diazepam; Dose-Response Relationship, Drug; Erythromycin; Folic Acid; Humans; Information Systems; Lung Neoplasms; Multiple Myeloma; Neoplasms; Product Surveillance, Postmarketing; Vitamin E | 1990 |
On therapeutic approaches to some special types of acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Androgen Antagonists; Anti-Inflammatory Agents; Benzoyl Peroxide; Clindamycin; Cyproterone; Cyproterone Acetate; Diazepam; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Erythromycin; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Male; Sulfamethoxazole; Tetracycline; Tretinoin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Management of tetanus.
Topics: Aged; Aged, 80 and over; Chlorpromazine; Clostridium tetani; Darkness; Diazepam; Erythromycin; Female; Humans; Intensive Care Units; Middle Aged; Morphine; Ranitidine; Tetanus; Tetanus Toxoid | 1987 |
Binding of 8-methoxypsoralen to human serum proteins and red blood cells.
Topics: Binding Sites; Blister; Blood Proteins; Diazepam; Erythrocytes; Erythromycin; Humans; Indomethacin; Methoxsalen; Protein Binding; Salicylates; Salicylic Acid; Warfarin | 1987 |
[Influence of various drugs and pH-values on albumin-bilirubin binding in vitro].
Topics: Ampicillin; Bilirubin; Carbenicillin; Cephalothin; Cloxacillin; Colistin; Diazepam; Dicloxacillin; Drug Interactions; Erythromycin; Gentamicins; Hydrogen-Ion Concentration; Oxacillin; Protein Binding; Serum Albumin | 1973 |
[Does drug therapy increase the dangers of bilirubin encephalopathy during the newborn period?].
Topics: Ampicillin; Bilirubin; Blood; Carbenicillin; Cephalothin; Child, Preschool; Colistin; Diazepam; Erythromycin; Gentamicins; Humans; Hydrogen-Ion Concentration; Hyperbilirubinemia; Infant; Infant, Newborn; Infant, Premature; Kernicterus; Oxacillin; Phenobarbital | 1973 |
[Interference by drugs in the determination of urinary 17-hydroxycorticosteroid (17-OHCS) inhibition of color reaction in Porter-Silber reaction].
Topics: 17-Hydroxycorticosteroids; Amides; Amino Alcohols; Benzazepines; Diazepam; Dibenzazepines; Erythromycin; Humans; Ketones; Nitro Compounds; Phenethylamines; Prochlorperazine; Promethazine | 1971 |
[Effect of various drugs in vivo and in vitro on the results of the most frequently performed enzymatic determinations in a clinical laboratory].
Topics: Alanine Transaminase; Alkaline Phosphatase; Aminopyrine; Amylases; Antipyrine; Ascorbic Acid; Aspartate Aminotransferases; Chlorpropamide; Clinical Enzyme Tests; Diazepam; Drug Combinations; Enzyme Activation; Enzyme Inhibitors; Erythromycin; Female; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Pemoline; Phenylbutazone; Poland; Salicylates | 1980 |
Amino acid 305 determines catalytic center accessibility in CYP3A4.
Topics: Alanine; Amino Acid Substitution; Aryl Hydrocarbon Hydroxylases; Binding Sites; Catalysis; Clotrimazole; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diazepam; Econazole; Erythromycin; Humans; Imidazoles; Ketoconazole; Kinetics; Miconazole; Mixed Function Oxygenases; Multienzyme Complexes; Mutation; Nifedipine; Oxidoreductases, N-Demethylating; Substrate Specificity; Testosterone | 2000 |
CYP3A4 active site volume modification by mutagenesis of leucine 211.
Topics: Amino Acid Substitution; Anti-Anxiety Agents; Anti-Bacterial Agents; Binding Sites; Coumarins; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diazepam; Enzyme Activation; Enzyme Inhibitors; Erythromycin; Hydroxylation; Kinetics; Leucine; Mixed Function Oxygenases; Mutagenesis, Site-Directed; Oxidation-Reduction; Structure-Activity Relationship; Substrate Specificity; Testosterone; Troleandomycin | 2002 |
[BENZODIAZEPINE AS A COADJUVANT IN THE TREATMENT OF TETANUS].
Topics: Anti-Bacterial Agents; Benzodiazepines; Chlorpromazine; Diazepam; Drug Therapy; Erythromycin; Humans; Meprobamate; Penicillins; Promethazine; Protein Synthesis Inhibitors; Tetanus; Tetanus Toxoid; Tetracycline | 1964 |
Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: role of P-glycoprotein as a barrier to in vivo ocular drug absorption.
Topics: Absorption; Amino Acid Sequence; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carbon Radioisotopes; Cell Division; Cells, Cultured; Cornea; Diazepam; Dogs; Dose-Response Relationship, Drug; Erythromycin; Eye; Humans; Male; Mannitol; Molecular Sequence Data; Protein Biosynthesis; Protein Synthesis Inhibitors; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Sequence Homology, Amino Acid | 2004 |